Skip to main content
SpringerLink
Log in

Priv. Doz. Dr. Wolfgang Sieghart Researcher of the Month Juni 2013

  • MUW researcher of the month
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Sieghart W, Hucke F, Pinter M, Graziadei I, Vogel W, Müller C, Heinzl H, Trauner M, Peck-Radosavljevic M. The ART of decision making: retreatment with TACE in patients with hepatocellular carcinoma. Hepatology. In press 2013.

  2. Sieghart W, Pinter M, Hucke F, Graziadei I, Schöniger-Hekele M, Müller C, Vogel W, Trauner M, Peck-Radosavljevic M. A single determination of C-reactive protein at the time of diagnosis predicts long term outcome of patients with hepatocellular carcinoma. Hepatology. In press 2012. doi: 10.1002/hep.26057.

  3. Sieghart W, Wang X, Schmid K, Pinter M, König F, Bodingbauer M, Wrba F, Rasoul-Rockenschaub S, Peck-Radosavljevic M. Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond milan criteria. J Hepatol. 2011 Jan; 54(1):89–97.

    Article  CAS  PubMed  Google Scholar 

  4. Sieghart W, Fuereder T, Schmid K, Cejka D, Werzowa J, Wrba F, Wang X, et al. Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation. Transplantation. 2007; 83:425–32.

    Article  CAS  PubMed  Google Scholar 

  5. Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, et al. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. J Hepatol. 2006;44:151–7.

    Article  CAS  PubMed  Google Scholar 

  6. Sieghart W, Pinter M, Dauser B, Rohr-Udilova N, Piguet AC, Prager G, Hayden H, Dienes HP, Dufour JF, Peck-Radosavljevic M. Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. J Hepatol. 2012 Sep; 57(3):592–9.

    Article  CAS  PubMed  Google Scholar 

  7. Rohr-Udilova N, Sieghart W, Eferl R, Stoiber D, Björkhem-Bergman L, Eriksson LC, Stolze K, Hayden H, Keppler B, Sagmeister S, Grasl-Kraupp B, Schulte-Hermann R, Peck-Radosavljevic M. Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. Hepatology. 2012 Apr;55(4):1112–21.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie, Währinger Gürtel 18–20, 1090, Wien, Österreich

    Wolfgang Sieghart

Authors
  1. Wolfgang Sieghart
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sieghart, W. Priv. Doz. Dr. Wolfgang Sieghart Researcher of the Month Juni 2013. Wien Klin Wochenschr 125, 348–349 (2013). https://doi.org/10.1007/s00508-013-0393-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-013-0393-4

Search

Navigation